“…Accordingly, the use of dexamethasone could be combined with tissue engineering strategies, such as substrate functionalization with biodegradable hydrogels and porous CPs, for its controlled local release in order to specifically target its activity around the implant, while reducing potential side effects caused by its systemic toxicity at too high doses. In relation to this approach, one of the first in vitro attempts to control the release of dexamethasone from a conducting polymer coating of PPy on Au electrode 2018) Lago et al, 2007;Garde et al, 2009;Mercanzini et al, 2010;Chang et al, 2013;Hassler et al, 2016;Oddo et al, 2016;Boehler et al, 2017;Delgado-Martínez et al, 2017;Wurth et al, 2017;de la Oliva et al, 2018b,c;Ji et al, 2018;Kang et al, 2019;Lee et al, 2019;Rombaut et al, 2019 Parylene C Reviewed in Fekete andPongrácz (2017) Ziegler et al, 2006;Sohal et al, 2014;Xie et al, 2014;Lecomte et al, 2017;Mueller et al, 2017;de la Oliva et al, 2018a,b;Vitale et al, 2018;Kang et al, 2019PDMS Blau et al, 2011Gao et al, 2013;Guo et al, 2014;Minev et al, 2015;Chatzimichail et al, 2018;Kumar et Poly(carboxybetaine) and pCBMA Jiang and Cao, 2010;Carr et al, 2011;Zhang et al, 2013;Trel'Ová et al, 2019 Phosphorylcholine self-assembled monolayers Chen et al, 2005 Poly(sulfobetaine) and pSBMA Reviewed in Sin et al (2014a) Jiang and...…”